L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
US6455690B1 · kind B1 · utility
43Cited by
1References
1Claims
0Family size
Inventors
Key dates
| Filing date | Jun 15, 2000 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Jun 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel nucleosides having the structure of Formula 1 and Formula 2 are contemplated. In one aspect of the invention, controlled release dosage forms are particularly contemplated. Further, alternative routes of administration of the nucleosides having the structure of Formula 1 or Formula 2 are contemplated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.